Department of Surgery, University of Colorado Denver, Anschutz Medical Campus, Aurora, Colorado, USA.
Colorado Center for Transplantation Care, Research and Education (CCTCARE), Aurora, Colorado, USA.
Liver Transpl. 2023 Jul 1;29(7):724-734. doi: 10.1097/LVT.0000000000000075. Epub 2023 Feb 7.
Perioperative dysfunction of the fibrinolytic system may play a role in adverse outcomes for liver transplant recipients. There is a paucity of data describing the potential impact of the postoperative fibrinolytic system on these outcomes. Our objective was to determine whether fibrinolysis resistance (FR), on postoperative day one (POD-1), was associated with early allograft dysfunction (EAD). We hypothesized that FR, quantified by tissue plasminogen activator thrombelastography, is associated with EAD. Tissue plasminogen activator thrombelastography was performed on POD-1 for 184 liver transplant recipients at a single institution. A tissue plasminogen activator thrombelastography clot lysis at 30 minutes of 0.0% was identified as the cutoff for FR on POD-1. EAD occurred in 32% of the total population. Fifty-nine percent (n=108) of patients were categorized with FR. The rate of EAD was 42% versus 17%, p <0.001 in patients with FR compared with those without, respectively. The association between FR and EAD risk was assessed using multivariable logistic regression after controlling for known risk factors. The odds of having EAD were 2.43 times (95% CI, 1.07-5.50, p =0.03) higher in recipients with FR [model C statistic: 0.76 (95% CI, 0.64-0.83, p <0.001]. An additive effect of receiving a donation after circulatory determination of death graft and having FR in the rate of EAD was observed. Finally, compared with those without FR, recipients with FR had significantly shorter graft survival time ( p =0.03). In conclusion, FR on POD-1 is associated with EAD and decreased graft survival time. Postoperative viscoelastic testing may provide clinical utility in identifying patients at risk for developing EAD, especially for recipients receiving donation after circulatory determination of death grafts.
围手术期纤溶系统功能障碍可能与肝移植受者的不良结局有关。目前描述术后纤溶系统对这些结局潜在影响的数据很少。我们的目的是确定术后第 1 天(POD-1)的纤维蛋白溶解抵抗(FR)是否与早期移植物功能障碍(EAD)相关。我们假设,组织型纤溶酶原激活物血栓弹力图量化的 FR 与 EAD 相关。在一家机构对 184 例肝移植受者进行了 POD-1 组织型纤溶酶原激活物血栓弹力图检查。将 POD-1 时 30 分钟的组织型纤溶酶原激活物血栓弹力图纤维蛋白溶解率 0.0%定义为 FR 的截止值。总人群中 EAD 的发生率为 32%。59%(n=108)的患者被归类为 FR。与无 FR 患者相比,FR 患者的 EAD 发生率分别为 42%和 17%,p<0.001。在控制已知危险因素后,使用多变量逻辑回归评估 FR 与 EAD 风险之间的关系。在 FR 患者中,EAD 的发生风险是无 FR 患者的 2.43 倍(95%CI,1.07-5.50,p=0.03)[模型 C 统计量:0.76(95%CI,0.64-0.83,p<0.001]。在 EAD 发生率中观察到循环死亡器官确定供体供肝和 FR 的接受者中存在相加效应。最后,与无 FR 患者相比,有 FR 的患者移植物存活时间明显缩短(p=0.03)。总之,POD-1 的 FR 与 EAD 和移植物存活时间缩短有关。术后黏弹性检测可能为识别发生 EAD 风险的患者提供临床实用性,特别是对于接受循环死亡器官确定供体供肝的受者。